Eisenmenger’s syndrome historical perspective

Jump to navigation Jump to search

Eisenmenger’s syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Eisenmenger’s syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Eisenmenger’s syndrome ACC/AHA Guidelines for Evaluation of Patients

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

ACC/AHA Guidelines for Reproduction

Eisenmenger’s syndrome historical perspective On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Eisenmenger’s syndrome historical perspective

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Eisenmenger’s syndrome historical perspective

CDC on Eisenmenger’s syndrome historical perspective

Eisenmenger’s syndrome historical perspective in the news

Blogs on Eisenmenger’s syndrome historical perspective

Directions to Hospitals Treating Type page name here

Risk calculators and risk factors for Eisenmenger’s syndrome historical perspective

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Abdelrahman Ibrahim Abushouk, MD[2]

Overview

Historical Perspective

Eisenmenger syndrome was initially described in 1897, when Victor Eisenmenger reported on a patient with symptoms of dyspnea and cyanosis from infancy who subsequently developed heart failure and succumbed to massive hemoptysis.[1] An autopsy revealed a large ventricular septal defect (VSD) and an overriding aorta. This was the first description of a link between a large congenital cardiac shunt defect and the development of pulmonary hypertension.

Advances in the medical treatment of patients with severe pulmonary hypertension may improve survival in patients with Eisenmenger syndrome and may potentially reverse the process in selected patients to a point at which they again become candidates for surgical repair.[2]

References

  1. Eisenmenger, Vector (1897). "Die angeborenens Defecte der Kammerschieidewand des Herzen". Z Klin Med. 32: I-28.
  2. Beghetti M, Galiè N (2009). "Eisenmenger syndrome a clinical perspective in a new therapeutic era of pulmonary arterial hypertension". J Am Coll Cardiol. 53 (9): 733–40. doi:10.1016/j.jacc.2008.11.025. PMID 19245962.

Template:WH Template:WS